Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2023 Jan 31;14:1140018. doi: 10.3389/fphar.2023.1140018

Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Minglu Liu 1, Tong Hu 2,3, Wenfeng Gou 2, Huajie Chang 2, Yanli Li 2, Yiliang Li 2, Daiying Zuo 3, Wenbin Hou 2,*, Shunchang Jiao 1,*
PMCID: PMC9927636  PMID: 36798079

In the published article, there was an error in the Author list. The corrected author list appears below:

“Minglu Liu1, Tong Hu2,3, Wenfeng Gou2, Huajie Chang2, Yanli Li2, Yiliang Li2, Daiying Zuo3, Wenbin Hou2,*, Shunchang Jiao1,*”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES